| 02.11.2022 07:01 | GSK | 3rd Quarter Results | RNS |
| 02.11.2022 07:00 | GSK | GSK RSV vaccine: US FDA Priority Review | RNS |
| 01.11.2022 15:00 | GSK | Total Voting Rights | RNS |
| 31.10.2022 14:28 | GSK, HLN | Haleon announces results for exchange offers from GSK spin-off | Alliance |
| 28.10.2022 08:44 | GSK | TOP NEWS: GSK gets support from European panel for HIV prevention | Alliance |
| 28.10.2022 07:00 | GSK | EMA validates MAA for cabotegravir LA for PrEP | RNS |
| 28.10.2022 07:00 | GSK | EMA accepts GSK RSV older adult vaccine for review | RNS |
| 27.10.2022 10:02 | GSK | US FDA advisory panel votes against GSK kidney drug use in some cases | Alliance |
| 27.10.2022 07:05 | GSK | GSK announces FDA meeting outcome on daprodustat | RNS |
| 27.10.2022 07:00 | GSK | ContRAst phase III programme for otilimab update | RNS |
| 26.10.2022 15:53 | WIZZ, WEIR, SKG | UK earnings, trading statements calendar - next 7 days | Alliance |
| 25.10.2022 10:00 | GSK | Board Committee Changes | RNS |
| 24.10.2022 10:28 | GSK, SAR | IN BRIEF: Sareum widens annual loss; considers future of SRA737 | Alliance |
| 21.10.2022 09:10 | GSK | GSK says respiratory vaccine candidate accepted for review in Japan | Alliance |
| 21.10.2022 07:00 | GSK | RSV older adult vaccine submission in Japan | RNS |
| 17.10.2022 08:54 | GSK | TOP NEWS: GSK hails Menveo vaccine approval in one-vial presentation | Alliance |
| 17.10.2022 07:00 | GSK | Menveo new single-vial approved by US FDA | RNS |
| 14.10.2022 14:11 | GSK | Director/PDMR Shareholding | RNS |
| 14.10.2022 09:17 | BHP, SBRE, LTG | LONDON BROKER RATINGS: Peel Hunt likes Petrofac; Deutsche cuts boohoo | Alliance |
| 13.10.2022 12:46 | GSK | Director/PDMR Shareholding | RNS |
| 13.10.2022 09:44 | GSK | Director/PDMR Shareholding | RNS |
| 13.10.2022 09:24 | GSK | TOP NEWS: GSK hails vaccine success for severe virus in older people | Alliance |
| 13.10.2022 08:26 | GSK | Director/PDMR Shareholding | RNS |
| 13.10.2022 07:00 | GSK | Efficacy results for GSK’s older adult RSV vaccine | RNS |
| 12.10.2022 11:42 | GSK | Director/PDMR Shareholding | RNS |
| 12.10.2022 10:47 | SAR, GSK | Sareum plunges as GSK subsidiary Sierra returns rights for SRA737 | Alliance |
| 10.10.2022 08:55 | GSK | US FDA approves GSK's Boostrix to prevent whooping cough in newborns | Alliance |
| 10.10.2022 07:00 | GSK | US FDA approves Boostrix maternal immunisation | RNS |
| 07.10.2022 16:38 | GSK | Director/PDMR Shareholding | RNS |
| 07.10.2022 16:24 | GSK | Director/PDMR Shareholding | RNS |
| 05.10.2022 09:06 | GSK | GSK lung cancer drug Jemperli to advance to phase 3 study | Alliance |
| 04.10.2022 11:07 | GSK | IN BRIEF: MGC Pharmaceuticals appoints Yifat Steuer deputy CEO | Alliance |
| 03.10.2022 10:10 | GSK | Total Voting Rights | RNS |
| 30.09.2022 17:21 | GSK | Director/PDMR Shareholding | RNS |
| 29.09.2022 15:42 | WEIR, VSL, VTY | UK dividends calendar - next 7 days | Alliance |
| 29.09.2022 09:36 | BOO, XLM, FERG | LONDON BROKER RATINGS: GSK raised to 'outperform'; RBC cuts THG | Alliance |
| 28.09.2022 08:40 | GSK, BRBY | TOP NEWS: Burberry hires new chief creative officer as Tisci departs | Alliance |
| 26.09.2022 17:09 | GSK | Director/PDMR Shareholding | RNS |
| 26.09.2022 09:11 | HLN, GSK, ULVR | TOP NEWS: Unilever CEO Alan Jope to step down next year | Alliance |
| 26.09.2022 08:55 | AZN, BRBY, GSK | TOP NEWS: GSK names Burberry's Julie Brown as new CFO from May | Alliance |
| 26.09.2022 07:00 | GSK | GSK Chief Financial Officer succession | RNS |
| 23.09.2022 06:57 | GSK | GSK cancer drug Zejula to be reviewed by US health watchdog | Alliance |
| 22.09.2022 14:00 | GSK | US FDA ODAC review of Zejula Phase III NOVA trial | RNS |
| 22.09.2022 08:43 | GSK | TOP NEWS: GSK signs licence deal for Spero's tebipenem HBr antibiotic | Alliance |
| 22.09.2022 07:00 | GSK | GSK and Spero Therapeutics licence for tebipenem | RNS |
| 21.09.2022 11:22 | GSK | Director/PDMR Shareholding | RNS |
| 20.09.2022 10:59 | GSK, HLN | TOP NEWS SUMMARY: Haleon makes positive start separate from GSK | Alliance |
| 20.09.2022 09:08 | GSK, HLN | TOP NEWS: Haleon makes good earnings debut with interim revenue rise | Alliance |
| 16.09.2022 08:16 | GSK, AZN | TOP NEWS: Two AstraZeneca drugs get recommendations for EU approval | Alliance |
| 15.09.2022 09:30 | FEVR, JSG, ITM | LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK | Alliance |
| 14.09.2022 09:40 | FEVR, TET, GAMA | LONDON BROKER RATINGS: Stifel downgrades IAG, easyJet and Ryanair | Alliance |
| 13.09.2022 09:11 | GSK | Director/PDMR Shareholding | RNS |
| 09.09.2022 14:34 | GSK | GSK says niraparib shows sustained benefit in ovarian cancer patients | Alliance |
| 09.09.2022 09:11 | GSK | Publication of Base Prospectus | RNS |
| 08.09.2022 12:58 | GSK | Director/PDMR Shareholding | RNS |
| 08.09.2022 09:22 | ENQ, TET, AIBG | LONDON BROKER RATINGS: Morgan Stanley cuts ITV to 'underweight' | Alliance |
| 07.09.2022 09:47 | WPS, ITM, SVS | LONDON BROKER RATINGS: UBS raises Admiral; Morgan Stanley cuts Astra | Alliance |
| 06.09.2022 14:07 | GSK | GSK malaria vaccine gets WHO boost; FDA reviews kidney disease drug | Alliance |
| 06.09.2022 13:00 | GSK | GSK provides update on FDA review of daprodustat | RNS |
| 01.09.2022 11:48 | GSK | Total Voting Rights | RNS |
| 01.09.2022 10:13 | GSK | GSK to present data on ovarian and endometrial cancer drugs in Paris | Alliance |
| 24.08.2022 07:00 | GSK | GSK Board changes | RNS |
| 22.08.2022 16:53 | GSK | Director/PDMR Shareholding | RNS |
| 18.08.2022 09:43 | ITM, DEVO, HOC | LONDON BROKER RATINGS: Jefferies likes AO, Berenberg lifts Devolver | Alliance |
| 17.08.2022 08:17 | GSK | TOP NEWS: US FDA accepts GSK's new drug application for momelotinib | Alliance |
| 17.08.2022 07:00 | GSK | FDA New Drug Application File Acceptance for MMB | RNS |
| 17.08.2022 07:00 | GSK | Statement: Zantac (ranitidine) litigation update | RNS |
| 16.08.2022 20:06 | HLN, GSK | TOP NEWS: GSK scores victory as first Zantac dismissed from court | Alliance |
| 16.08.2022 08:29 | GSK | GSK completes acquisition of biopharmaceutical firm Affinivax | Alliance |
| 16.08.2022 07:06 | GSK | GSK completes acquisition of Affinivax, Inc. | RNS |
| 12.08.2022 08:11 | HLN, GSK, LSEG | LONDON BRIEFING: Haleon, GSK, Pfizer and Sanofi respond on Zantac hit | Alliance |
| 12.08.2022 07:00 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 12.08.2022 06:48 | HLN, GSK | TOP NEWS: Pfizer and Haleon distance themselves from Zantac litigation | Alliance |
| 11.08.2022 21:41 | GSK | TOP NEWS: GSK, Sanofi say Zantac science backs defence over litigation | Alliance |
| 11.08.2022 15:40 | GSEO, UKCM, TIFS | UK dividends calendar - next 7 days | Alliance |
